Novartis CEO says it won't join weight-loss drug frenzy
The CEO of Novartis The Swiss pharmaceutical giant has no intention of getting into the “frenzy” of weight loss drugs,…
Biotechnology and pharmaceuticals
Roche releases more data on slimming pills and injections
Headquarters of Roche, a multinational pharmaceutical industry on December 27, 2021 in Madrid, Spain. Cristina Arias | Cover | Getty…
Race for radiopharmaceuticals intensifies as drugmakers chase Novartis
Drug makers are betting that delivering radiation directly to tumors will become the next big cancer breakthrough. Bristol-Myers Squibb, AstraZeneca,…
Pfizer's drug for cancer cachexia shows positive results in mid-phase trials
PfizerPfizer's experimental drug for a common, potentially fatal disease that causes cancer patients to lose appetite and weight showed positive…
Florida advises against the use of mRNA vaccines against Covid in older adults
As the Covid wave continues in Florida, Gov. Ron DeSantis' administration is again advising against mRNA vaccines — this time…
$1 billion in cost cuts and 10 planned product launches
Moderna headquarters, exterior view, Cambridge, Massachusetts, USA. Plexi Images | GHI | UCG | Universal Images Group | Getty Images…
Eli Lilly to increase production of weight loss, diabetes and Alzheimer's drugs
A sign with the company logo is displayed outside Eli Lilly headquarters in Indianapolis, Indiana, March 17, 2024. Scott Olson…
57 million privately insured adults are eligible to receive GLP-1
Slimming syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Image…
AstraZeneca shares fall 5% on disappointing lung cancer drug trial
AstraZeneca Shares fell more than 5% on Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical…
Eli Lilly could become the first $1 trillion healthcare stock
A sign with the company logo is displayed outside the headquarters of Eli Lilly and Company in Indianapolis, Indiana, on…